Back to Search
Start Over
Plaque Psoriasis Pipeline, Clinical Trials Assessment, NDA Approvals 2023 (Updated) | Arcutis Biotherapeutics, Affibody, Akeso Biopharma, Dong-A ST Co., Ltd., DelArrivo, Inc., and others
- Source :
- M2 Presswire. July 17, 2023
- Publication Year :
- 2023
-
Abstract
- M2 PRESSWIRE-July 17, 2023-: Plaque Psoriasis Pipeline, Clinical Trials Assessment, NDA Approvals 2023 (Updated) | Arcutis Biotherapeutics, Affibody, Akeso Biopharma, Dong-A ST Co., Ltd., DelArrivo, Inc., and others (C)1994-2023 M2 [...]
- Subjects :
- Psoriasis -- Reports
Biological products industry -- Product development
Business -- Research
Medical research -- Reports
Medicine, Experimental -- Reports
Alefacept -- Reports
Dermatology -- Formulae, receipts, prescriptions
Clinical trials -- Reports
Adalimumab -- Product development
Dermatologic agents -- Product development
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.757390224